unknown
Stage
2
Investors
About
Valcare develops minimally invasive transcatheter solutions for mitral regurgitation and structural heart valve disease — opening new horizons.
Explore Valcare Medical's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.